Algert Global LLC Boosts Stake in Oscar Health, Inc. (NYSE:OSCR)

Algert Global LLC raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 63.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 369,685 shares of the company's stock after purchasing an additional 143,346 shares during the period. Algert Global LLC owned 0.15% of Oscar Health worth $7,841,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of OSCR. Point72 Hong Kong Ltd bought a new position in Oscar Health during the second quarter worth about $78,000. Quest Partners LLC acquired a new position in Oscar Health during the second quarter worth $93,000. KBC Group NV grew its position in Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after purchasing an additional 1,328 shares in the last quarter. Amalgamated Bank increased its position in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after acquiring an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors acquired a new position in shares of Oscar Health during the 3rd quarter worth approximately $142,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently weighed in on OSCR. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. UBS Group started coverage on Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective on the stock. Finally, Piper Sandler reiterated an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $22.93.

Insider Activity at Oscar Health

In other news, Vice Chairman Joshua Kushner acquired 276,040 shares of Oscar Health stock in a transaction on Monday, November 11th. The stock was acquired at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now owns 5,031,262 shares of the company's stock, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares of the company's stock, valued at $6,697,875.42. The trade was a 4.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. 25.11% of the stock is owned by insiders.

Oscar Health Stock Down 2.0 %

Shares of Oscar Health stock traded down $0.33 during trading hours on Friday, reaching $15.98. The company's stock had a trading volume of 5,131,339 shares, compared to its average volume of 5,597,619. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock's fifty day simple moving average is $17.90 and its two-hundred day simple moving average is $18.20. The company has a market capitalization of $3.95 billion, a P/E ratio of -266.33 and a beta of 1.67. Oscar Health, Inc. has a one year low of $7.29 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. Oscar Health's revenue was up 68.3% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.29) EPS. On average, research analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.